Cargando…

Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome

BACKGROUND: Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) symptoms often overlap. In some IBS cases there are subtle inflammatory changes similar to the immune-mediated pathophysiology of IBD, and the risk of both increases after infectious gastroenteritis (IGE). METHODS: To ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porter, Chad K, Cash, Brooks D, Pimentel, Mark, Akinseye, Akintunde, Riddle, Mark S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444908/ https://www.ncbi.nlm.nih.gov/pubmed/22639930 http://dx.doi.org/10.1186/1471-230X-12-55

Ejemplares similares

Estimating the Contribution of Acute Gastroenteritis to the Overall Prevalence of Irritable Bowel Syndrome
por: Shah, Eric D, et al.
Publicado: (2012)

Irritable Bowel Syndrome Is Not Associated with an Increased Risk of Polyps and Colorectal Cancer: A Systematic Review and Meta-Analysis
por: Vichos, Theodoros, et al.
Publicado: (2023)

Montezuma’s revenge - the sequel: The one-hundred year anniversary of the first description of “post-infectious” irritable bowel syndrome
por: Riddle, Mark S, et al.
Publicado: (2018)

Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017)

The Epidemiology of Irritable Bowel Syndrome in the US Military: Findings from the Millennium Cohort Study
por: Riddle, Mark S, et al.
Publicado: (2016)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome
por: Major, Giles, et al.
Publicado: (2014)

Volatomics in inflammatory bowel disease and irritable bowel syndrome
por: Van Malderen, Kathleen, et al.
Publicado: (2020)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Irritable bowel syndrome diagnosis
por: Tyllis, Nick
Publicado: (2019)

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update
por: Takakura, Will, et al.
Publicado: (2020)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
por: Min, Yang Won, et al.
Publicado: (2022)

Psychological Interventions for Irritable Bowel Syndrome and Inflammatory Bowel Diseases
por: Ballou, Sarah, et al.
Publicado: (2017)

Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome
por: Fournier, Alicia, et al.
Publicado: (2020)

Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
por: Shah, Eric, et al.
Publicado: (2014)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness
por: Porter, Chad K, et al.
Publicado: (2013)

Prevalence of irritable bowel syndrome and functional abdominal pain disorders in children with inflammatory bowel disease in remission
por: Limbri, Lydia F, et al.
Publicado: (2022)

Symptomatology of irritable bowel syndrome and inflammatory bowel disease during the menstrual cycle
por: Bharadwaj, Shishira, et al.
Publicado: (2015)

Experiences of healing therapy in patients with irritable bowel syndrome and inflammatory bowel disease
por: Soundy, Andrew, et al.
Publicado: (2015)

Are Probiotics or Prebiotics Useful in Pediatric Irritable Bowel Syndrome or Inflammatory Bowel Disease?
por: Guandalini, Stefano
Publicado: (2014)

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases
por: Ceuleers, Hannah, et al.
Publicado: (2016)

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Lo Presti, Alessandra, et al.
Publicado: (2019)

Proinflammatory cytokines in irritable bowel syndrome: a comparison with inflammatory bowel disease
por: Mitselou, Antigony, et al.
Publicado: (2020)

(Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review
por: Hagan, Marilyn, et al.
Publicado: (2021)

Efficacy of a Digital Personalized Elimination Diet for the Self-Management of Irritable Bowel Syndrome and Comorbid Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Jactel, Samuel N., et al.
Publicado: (2022)

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
por: Lembo, Anthony, et al.
Publicado: (2020)

Contemporary diagnosis and management of irritable bowel syndrome /
por: Drossman, Douglas A.
Publicado: (2002)

An expert system for the diagnosis of irritable bowel syndrome
por: SURDEA-BLAGA, TEODORA, et al.
Publicado: (2013)

Update in diagnosis and management of irritable bowel syndrome
por: Hung, Tsung-Hsing, et al.
Publicado: (2023)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms
por: Cash, Brooks D., et al.
Publicado: (2015)

Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial
por: Cash, Brooks D., et al.
Publicado: (2017)

Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place
por: Abdul Rani, Rafiz, et al.
Publicado: (2016)

Irritable Brain Caused by Irritable Bowel? A Nationwide Analysis for Irritable Bowel Syndrome and Risk of Bipolar Disorder
por: Liu, Chia-Jen, et al.
Publicado: (2015)

Erratum to: Experiences of healing therapy in patients with irritable bowel syndrome and inflammatory bowel disease
por: Soundy, Andrew, et al.
Publicado: (2015)

Is irritable bowel syndrome a dysbiotic bowel syndrome?
por: Benno, Peter, et al.
Publicado: (2015)

Repeat Rifaximin for Irritable Bowel Syndrome: No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity
por: Pimentel, M., et al.
Publicado: (2017)

Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients
por: de Graaf, Marlijne C. G., et al.
Publicado: (2022)

Irritable Bowel Syndrome Is an Independent Risk Factor for Developing Opioid Use Disorder in Patients with Inflammatory Bowel Disease
por: Fu, Yuhan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2peoc1v5pnk559kuvhjajrhpp9